BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28079594)

  • 1. Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis.
    Beg MS; Gupta A; Sher D; Ali S; Khan S; Gao A; Stewart T; Ahn C; Berry J; Mortensen EM
    Am J Clin Oncol; 2018 Aug; 41(8):766-771. PubMed ID: 28079594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis.
    Yang A; Zylberberg HM; Rustgi SD; Amin SP; Bar-Mashiah A; Boffetta P; Lucas AL
    Sci Rep; 2021 Jan; 11(1):1038. PubMed ID: 33441781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
    Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
    PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
    Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
    Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
    Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
    JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
    E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
    Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
    [No Abstract]   [Full Text] [Related]  

  • 9. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.
    Nipp R; Tramontano AC; Kong CY; Pandharipande P; Dowling EC; Schrag D; Hur C
    Cancer Med; 2018 Feb; 7(2):525-535. PubMed ID: 29322643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
    Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
    J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
    Worni M; Guller U; White RR; Castleberry AW; Pietrobon R; Cerny T; Gloor B; Koeberle D
    Pancreas; 2013 Oct; 42(7):1157-63. PubMed ID: 23867367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
    Oncologist; 2018 Jun; 23(6):704-711. PubMed ID: 29445028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Metformin Use Associated with Prolonged Overall Survival in Patients with Soft Tissue Sarcoma? A SEER-Medicare Study.
    Hutchinson ID; Ata A; DiCaprio MR
    Clin Orthop Relat Res; 2022 Apr; 480(4):735-744. PubMed ID: 34779790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: a population-based analysis.
    Shen C; Shih YC; Xu Y; Yao JC
    Cancer; 2014 Jul; 120(13):2039-49. PubMed ID: 24676892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUS and survival in patients with pancreatic cancer: a population-based study.
    Ngamruengphong S; Li F; Zhou Y; Chak A; Cooper GS; Das A
    Gastrointest Endosc; 2010 Jul; 72(1):78-83, 83.e1-2. PubMed ID: 20620274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer.
    Wu BU; Chang J; Jeon CY; Pandol SJ; Huang B; Ngor EW; Difronzo AL; Cooper RM
    Am J Gastroenterol; 2015 Aug; 110(8):1233-9. PubMed ID: 26195180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.